Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Echinococcus multilocularis | multidrug resistance associated protein 4 | 0.0011 | 0.0946 | 0.0946 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0018 | 0.2763 | 0.1224 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.1753 | 0.1753 |
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.0018 | 0.2763 | 0.1224 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.1753 | 0.1753 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0044 | 1 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 7 | 0.0018 | 0.2763 | 0.2763 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0044 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.0018 | 0.2763 | 0.195 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0044 | 1 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.1753 | 0.1753 |
Entamoeba histolytica | multidrug resistance protein, putative | 0.0018 | 0.2763 | 0.1224 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0033 | 0.7063 | 0.6756 |
Giardia lamblia | MRP-like ABC transporter | 0.0018 | 0.2763 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.2763 | 0.1224 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0033 | 0.7062 | 0.6755 |
Trichomonas vaginalis | taga, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Onchocerca volvulus | 0.0014 | 0.1753 | 0.5 | |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.2763 | 0.1224 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0044 | 1 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.1753 | 0.1753 |
Echinococcus multilocularis | multidrug resistance associated protein 1 | 0.0018 | 0.2763 | 0.2763 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.2763 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Trypanosoma cruzi | multidrug resistance protein E, putative | 0.0018 | 0.2763 | 0.2006 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.1753 | 0.0828 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0044 | 1 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0044 | 1 | 1 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0014 | 0.169 | 0.169 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.2763 | 0.1224 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.2763 | 0.2006 |
Leishmania major | pentamidine resistance protein 1 | 0.0018 | 0.2763 | 0.1224 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0044 | 1 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.1753 | 0.1753 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.2763 | 0.1224 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.1753 | 0.1753 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.1753 | 0.1753 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.1753 | 0.0828 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0044 | 1 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.1753 | 0.1753 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.2763 | 0.1224 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Giardia lamblia | ABC transporter, putative | 0.0018 | 0.2763 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 4 | 0.0011 | 0.0946 | 0.0946 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.2763 | 0.2006 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.1753 | 0.1753 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0044 | 1 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.1753 | 0.1753 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.2763 | 0.195 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.2763 | 0.1224 |
Echinococcus granulosus | multidrug resistance associated protein 1 | 0.0018 | 0.2763 | 0.2763 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0014 | 0.169 | 0.169 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.1753 | 0.1753 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0044 | 1 | 1 |
Trypanosoma brucei | trans-sialidase, putative | 0.0033 | 0.7063 | 0.5942 |
Echinococcus multilocularis | multidrug resistance associated protein 7 | 0.0018 | 0.2763 | 0.2763 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0014 | 0.1753 | 0.5 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.2763 | 0.1224 |
Trypanosoma brucei | trans-sialidase, putative | 0.0033 | 0.7063 | 0.5942 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0044 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0018 | 0.2763 | 0.1224 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.2763 | 0.1224 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.1753 | 0.1753 |
Leishmania major | p-glycoprotein e | 0.0018 | 0.2763 | 0.1224 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0044 | 1 | 1 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0044 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.169 | 0.0757 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.0018 | 0.2763 | 0.1224 |
Brugia malayi | ABC transporter transmembrane region family protein | 0.0018 | 0.2763 | 0.1224 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.2699 | 0.188 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.0018 | 0.2763 | 0.1224 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0014 | 0.1753 | 0.0828 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.2763 | 0.195 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Trypanosoma brucei | trans-sialidase, putative | 0.0033 | 0.7063 | 0.5942 |
Leishmania major | ABC-thiol transporter | 0.0018 | 0.2763 | 0.1224 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.1753 | 0.1753 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0033 | 0.7063 | 0.6756 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0044 | 1 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0033 | 0.7063 | 0.6756 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.1753 | 0.1753 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.1753 | 0.1753 |
Trypanosoma brucei | trans-sialidase, putative | 0.0033 | 0.7063 | 0.5942 |
Trypanosoma brucei | trans-sialidase, putative | 0.0033 | 0.7063 | 0.5942 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.2763 | 1 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0044 | 1 | 1 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0044 | 1 | 1 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0033 | 0.7062 | 0.6755 |
Entamoeba histolytica | ABC transporter, putative | 0.0018 | 0.2763 | 0.1224 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.1753 | 0.1753 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0014 | 0.1753 | 0.0828 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0033 | 0.7062 | 0.6755 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.1753 | 0.1753 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.1753 | 0.1753 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0014 | 0.1753 | 0.5 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.0018 | 0.2763 | 0.1224 |
Brugia malayi | multidrug resistance related protein 1 | 0.0018 | 0.2763 | 0.1224 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0033 | 0.7062 | 0.6755 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0033 | 0.7063 | 0.6756 |
Trypanosoma brucei | trans-sialidase | 0.0033 | 0.7063 | 0.5942 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Secondary Concentration-Response Assay for Agonists of the Thyroid Stimulating Hormone Receptor: HTRF Activity Detection. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.